AstraZeneca

According to AstraZeneca, the vaccine is being withdrawn for commercial reasons as it "has been overtaken by updated vaccines that address the new Covid-19 variants"

In a significant move that reverberates across the global vaccination landscape, pharmaceutical giant AstraZeneca has announced a worldwide recall of its COVID-19 vaccine, citing an abundance of updated vaccine options in the wake of the pandemic's evolution. The decision comes amidst shifting demand dynamics and ongoing scrutiny surrounding the safety profile of the vaccine.

It is a document that was revealed in a trial following a collective lawsuit against the company – According to it “the vaccine can in very rare cases cause TTS or Thrombosis with Thrombocytopenia Syndrome”

COVID vaccination will probably be needed each year. This was stated by the CEO of Pfizer. Scientists believe they have found a link between the appearance of blood clots and the Astra Zeneca vaccine.

Bulgaria has stopped supplying vaccines from AstraZeneca, due to lack of interest in it and the risk of discarding the vaccines. In the last three months, there have been no deliveries of the AstraZeneca product in Bulgaria, according to data from the Ministry of Health.

According to a report by the People’s Vaccine Alliance, In contrast, AstraZeneca and Johnson & Johnson sell their vaccines at a cost price.

The British-Swedish pharmaceutical company AstraZeneca has requested an extraordinary permit for the use in the United States of its latest drug, which prevents COVID-19 disease. The drug, currently called AZD7442, is intended for people with weak immune systems, which would make vaccination ineffective.

The pharmaceutical company AstraZeneca announced it was seeking authorization for usage in US of a medicine related to the treatment from coronavirus infection. The medicine is aimed to prevent Covid-19 for people who respond poorly or do not respond at all to vaccines because of a weakened immune system, Reuters reported.

 The National Coordinating Committee for Activities on Vaccination against COVID-19 (CNCAV) reported on Thursday that, according to assessments, the thrombosis syndrome associated with thrombocytopenia (TTS) is an extremely rare adverse reaction after vaccination with the second dose of the AstraZeneca vaccine and the recommendation is to carry out the booster with the same type of vaccine, exc

Bulgaria will donate 172,500 Vaccines to Kingdom of Bhutan.

On July 22, 172,500 vaccines with the manufacturer AstraZeneca will be transported from Bul Bio - NCIPD to Sofia Airport, the Ministry of Health announced.